^
    Back
    Association details:
    Biomarker:ZNF268 overexpression
    Cancer:Breast Cancer
    Drug:cisplatin (DNA synthesis inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: D – Preclinical
    Source:
    Heliyon
    Title:

    The Expression of ZNF268 and Its Role in The Cisplatin-based Chemoresistance of Breast Cancer

    Published date:
    08/18/2023
    Excerpt:
    After collecting the breast cancer cell line MDA-MB-231 treated with or without cisplatin...We found that a high expression level of ZNF268 in breast cancer cell lines significantly enhances the sensitivity to cisplatin…
    DOI:
    https://doi.org/10.1016/j.heliyon.2023.e18779